Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Millan

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Current Opinion in Pharmacology|February 25, 2011
MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissuesMark J Millan
Pharmacology & Therapeutics|July 6, 2010
From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's diseaseMark J Millan
European Journal of Pharmacology|October 7, 2004
The role of monoamines in the actions of established and "novel" antidepressant agents: a critical reviewMark J Millan
Psychopharmacology|March 12, 2005
N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectivesMark J Millan
The International Journal of Neuropsychopharmacology|May 31, 2013
On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisalMark J Millan
The International Journal of Neuropsychopharmacology|November 2, 2006
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptorsMark J Millan, Anne Dekeyne
Psychopharmacology|August 19, 2008
Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterizationAnne Dekeyne, Mark J Millan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 17, 2008
Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonistsFlorence Loiseau, Mark J Millan
European Journal of Pharmacology|February 26, 2003
The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoaminesMark J Millan, Mauricette Brocco
Neuropharmacology|July 4, 2006
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserinAnne Dekeyne, Mark J Millan
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Current Opinion in Pharmacology|February 25, 2011
MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissuesMark J Millan
Pharmacology & Therapeutics|July 6, 2010
From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's diseaseMark J Millan
European Journal of Pharmacology|October 7, 2004
The role of monoamines in the actions of established and "novel" antidepressant agents: a critical reviewMark J Millan
Psychopharmacology|March 12, 2005
N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectivesMark J Millan
The International Journal of Neuropsychopharmacology|May 31, 2013
On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisalMark J Millan
The International Journal of Neuropsychopharmacology|November 2, 2006
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptorsMark J Millan, Anne Dekeyne
Psychopharmacology|August 19, 2008
Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterizationAnne Dekeyne, Mark J Millan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 17, 2008
Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonistsFlorence Loiseau, Mark J Millan
European Journal of Pharmacology|February 26, 2003
The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoaminesMark J Millan, Mauricette Brocco
Neuropharmacology|July 4, 2006
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserinAnne Dekeyne, Mark J Millan
Pageof 19